HPQ vs KYMR · P/E 8.6, rev $44.52B vs rev $99.4M
HP Inc (HPQ) versus Kymera Therapeutics Inc (KYMR) — a side-by-side from cached financials, not a winner call.
HP Inc (HPQ) is a computer hardware company listed on NYSE.
Kymera Therapeutics Inc (KYMR) is a biotechnology company listed on NASDAQ.
Latest reported HPQ revenue for 2026-07-31 was $44.52B. Net income was $1.66B. Revenue was up 54.3% from 2026-04-30 to 2026-07-31. HPQ currently screens at market cap $21.20B and trailing P/E 8.6.
Latest reported KYMR revenue for 2026-06-30 was $99.4M. Net income was -$130.4M. KYMR currently screens at market cap $7.39B.
HPQ currently screens at market cap $21.20B and trailing P/E 8.6. KYMR currently screens at market cap $7.39B.
Not investment advice. Open the HPQ and KYMR stock pages for the full models.
Not investment advice.